10x Genomics Inc’s filing revealed that its Chief Executive Officer Saxonov Serge unloaded Company’s shares for reported $0.21 million on Mar 04 ’24. In the deal valued at $44.00 per share,4,660 shares were sold. As a result of this transaction, Saxonov Serge now holds 842,900 shares worth roughly $25.96 million.
Then, Saxonov Serge sold 2,821 shares, generating $130,737 in total proceeds. Upon selling the shares at $46.34, the Chief Executive Officer now owns 847,560 shares.
Before that, Hindson Benjamin J. sold 2,613 shares. 10x Genomics Inc shares valued at $121,098 were divested by the insider at a price of $46.34 per share. As a result of the transaction, Hindson Benjamin J. now holds 283,059 shares, worth roughly $8.72 million.
Guggenheim initiated its 10x Genomics Inc [TXG] rating to a Buy in a research note published on December 14, 2023; the price target was $60. A number of analysts have revised their coverage, including Wolfe Research’s analysts, who began to cover the stock in mid December with a ‘”an Outperform”‘ rating. BofA Securities also remained covering TXG and has increased its forecast on December 12, 2023 with a “Neutral” recommendation from previously “an Underperform” rating.
Price Performance Review of TXG
On Tuesday, 10x Genomics Inc [NASDAQ:TXG] saw its stock fall -6.27% to $30.80. Over the last five days, the stock has lost -17.58%. 10x Genomics Inc shares have fallen nearly -44.96% since the year began. Nevertheless, the stocks have fallen -42.99% over the past one year. While a 52-week high of $63.57 was reached on 01/02/24, a 52-week low of $32.68 was recorded on 04/16/24. SMA at 50 days reached $40.98, while 200 days put it at $45.90. A total of 2.28 million shares were traded, compared to the trading of 1.19 million shares in the previous session.
Levels Of Support And Resistance For TXG Stock
The 24-hour chart illustrates a support level at 30.01, which if violated will result in even more drops to 29.21. On the upside, there is a resistance level at 31.89. A further resistance level may holdings at 32.98. The Relative Strength Index (RSI) on the 14-day chart is 26.27, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.95, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 93.89%. Stochastics %K at 3.65% indicates the stock is a buying.
The most recent change occurred on May 10, 2023 when Barclays began covering the stock and recommended ‘”an Overweight”‘ rating along with a $65 price target.
